Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden

The present study was performed to evaluate the efficacy of circulating cystatin-C as a tumor monitoring biomarker at different clinical time points in patients with breast cancer over a long-term follow-up period. In addition, the secretory rate of circulating cystatin-C from cancer tissue was inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Woo Sun, Kim, Tae Soo, Nahm, Chung Hyun, Moon, Yeonsook, Kim, Jin Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176264/
https://www.ncbi.nlm.nih.gov/pubmed/30344712
http://dx.doi.org/10.3892/ol.2018.9380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176264/
https://www.ncbi.nlm.nih.gov/pubmed/30344712
http://dx.doi.org/10.3892/ol.2018.9380

Ejemplares similares